In consultation: Guidance and quality standards
Showing 1 to 3 of 3
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Sodium zirconium cyclosilicate for treating hyperkalaemia (partial review of TA599) [ID6439] | Draft guidance | Technology appraisal guidance | |
| Sebetralstat for treating acute attacks of hereditary angioedema in people aged 12 and over [ID6284] | Draft guidance | Technology appraisal guidance | |
| Palopegteriparatide for treating chronic hypoparathyroidism [ID6380] | Draft guidance | Technology appraisal guidance |